| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.61 | 0.004 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |